AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $318,000 | +1.9% | 30,505 | -7.3% | 0.05% | +77.8% |
| Q1 2022 | $312,000 | -92.1% | 32,921 | -89.6% | 0.03% | -88.4% |
| Q2 2019 | $3,949,000 | -8.2% | 316,400 | 0.0% | 0.23% | -4.1% |
| Q1 2019 | $4,303,000 | +32.7% | 316,400 | -6.5% | 0.24% | +34.3% |
| Q4 2018 | $3,242,000 | +189.7% | 338,400 | +265.5% | 0.18% | +293.5% |
| Q3 2018 | $1,119,000 | -65.2% | 92,584 | -59.2% | 0.05% | -45.2% |
| Q2 2015 | $3,212,000 | +119.2% | 227,026 | +68.6% | 0.08% | +133.3% |
| Q1 2015 | $1,465,000 | +77.4% | 134,669 | +35.7% | 0.04% | -56.1% |
| Q4 2014 | $826,000 | +22.6% | 99,267 | -12.4% | 0.08% | +355.6% |
| Q3 2014 | $674,000 | – | 113,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |